1,3-Didecanoyl-2-(6-(5-Fluorouracil-1-Yl)Carbonylamino)hexanoylGlyceride
CAS : 81821-86-5
Ref. 3D-FD99334
| Taille indéfinie | Arrêté |
Informations sur le produit
Nom :
1,3-Didecanoyl-2-(6-(5-Fluorouracil-1-Yl)Carbonylamino)hexanoylGlyceride
Description :
1,3-Didecanoyl-2-(6-(5-fluorouracil-1-yl)carbonylamino)hexanoylglyceride (FURAC) is a prodrug that is converted to 5-fluorouracil in vivo. FURAC binds to the mitochondrial membrane and induces fission, which leads to an increase in potassium ion release and oxidative stress. This drug has been shown to have psychotic effects in animals, as well as anticancer properties for certain cells. It also induces DNA methylation and inhibition of histone acetylation. FURAC has hypotensive activity due to its ability to inhibit the renin-angiotensin system; this activity may be mediated by its ability to inhibit angiotensin II formation by blocking the conversion of angiotensin I into angiotensin II.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
669.82 g/mol
Formule :
C34H56FN3O9
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
